Metastatic basal cell carcinoma: response to chemotherapy.
Basal cell carcinoma is a common cutaneous neoplasm that rarely metastasizes. Unfortunately, there is little effective treatment available when metastasis does occur. Therefore potentially promising therapies for metastatic basal cell carcinoma should be reported. We report a case of basal cell carcinoma metastatic to bone, bone marrow, and the pleural cavity in a 51-year-old woman who showed a striking, albeit brief, response to treatment with a combination of cisplatin, bleomycin, methotrexate, and 5-fluorouracil.
Bason
M M
MM
Department of Medicine, Hartford Hospital, CT.
Grant-Kels
J M
JM
Govil
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000473:pathology / Q000556:secondary*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009333:Neck; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D010997:Pleural Neoplasms / Q000188:drug therapy / Q000556:secondary*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology